Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain

Biochemistry
Margery A ConnellyD L Williams

Abstract

Scavenger receptor BI (SR-BI) mediates the selective uptake of high-density lipoprotein (HDL) cholesteryl ester (CE), a process by which HDL CE is taken into the cell without degradation of the HDL particle. In addition, SR-BI stimulates the bi-directional flux of free cholesterol (FC) between cells and lipoproteins, an activity that may be responsible for net cholesterol efflux from peripheral cells as well as the rapid hepatic clearance of FC from plasma HDL. SR-BI also increases cellular cholesterol mass and alters cholesterol distribution in plasma membrane domains as judged by the enhanced sensitivity of membrane cholesterol to extracellular cholesterol oxidase. In contrast, CD36, a closely related class B scavenger receptor, has none of these activities despite binding HDL with high affinity. In the present study, analyses of chimeric SR-BI/CD36 receptors and domain-deleted SR-BI have been used to test the various domains of SR-BI for functional activities related to HDL CE selective uptake, bi-directional FC flux, and the alteration of membrane cholesterol mass and distribution. The results show that each of these activities localizes to the extracellular domain of SR-BI. The N-terminal cytoplasmic tail and transmembrane...Continue Reading

References

Dec 1, 1994·The Journal of Cell Biology·E J SmartR G Anderson
Sep 1, 1996·The Journal of Membrane Biology·A G BaillieN A Abumrad
Sep 13, 1996·The Journal of Biological Chemistry·N TaoD M Lublin
Jun 1, 1997·Current Opinion in Lipidology·A RigottiM Krieger
Aug 22, 1997·The Journal of Biological Chemistry·Y JiA R Tall
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A RigottiM Krieger
Jan 19, 1999·Annual Review of Cell and Developmental Biology·D A Brown, E London
Sep 11, 1999·Current Opinion in Lipidology·D L WilliamsG H Rothblat
Nov 7, 1999·The Journal of Biological Chemistry·H StanglH H Hobbs
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·M IkemotoK Inoue
Aug 31, 2000·Biochemical and Biophysical Research Communications·P GruarinM Alessio
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·A RadhakrishnanH M McConnell
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Jul 21, 2012·The Journal of Membrane Biology·Riki KawaguchiHui Sun
Oct 3, 2003·Biochemical and Biophysical Research Communications·Barbara PlayDominique Jourdheuil-Rahmani
Dec 4, 2003·Biochemical and Biophysical Research Communications·Magnus S C JohnsonBjörn Carlsson
Dec 3, 2003·Trends in Endocrinology and Metabolism : TEM·Margery A Connelly, David L Williams
Mar 30, 2013·Trends in Genetics : TIG·Kiran Mahajan, Nupam P Mahajan
Jun 6, 2002·Atherosclerosis·G H RothblatG Kellner-Weibel
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·David Rhainds, Louise Brissette
Feb 8, 2003·Atherosclerosis. Supplements·James S Owen, Jane V Mulcahy
Mar 12, 2008·The Journal of Biological Chemistry·Victor A DroverMichael C Phillips
May 29, 2004·Current Opinion in Lipidology·Margery A Connelly, David L Williams
Jun 11, 2002·Annual Review of Nutrition·Tahar Hajri, Nada A Abumrad
Sep 16, 2011·Journal of Lipid Research·Ling GuoXiang-An Li
Oct 3, 2012·PloS One·Alexandra C Chadwick, Daisy Sahoo
Feb 9, 2011·Current Atherosclerosis Reports·Ginny Kellner-Weibel, Margarita de la Llera-Moya
Feb 14, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Alexandra C Chadwick, Daisy Sahoo
Jan 15, 2013·Journal of Clinical Lipidology·Hicham BerrouguiAbdelouahed Khalil
Jan 13, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alvaro CerdaRosario D C Hirata
Mar 12, 2010·Archives of Biochemistry and Biophysics·Gabriella A PapaleDaisy Sahoo
Apr 8, 2006·Biochemical and Biophysical Research Communications·Koji MuraoToshihiko Ishida
Apr 21, 2005·The Journal of Clinical Investigation·Chatchawin AssanasenDavid L Silver
Oct 9, 2008·Molecular and Cellular Endocrinology·Margery A Connelly
Apr 21, 2006·Biochimica Et Biophysica Acta·Daisy SahooMargery A Connelly
Apr 8, 2015·PloS One·Alexandra C ChadwickDaisy Sahoo
Feb 11, 2003·Journal of Lipid Research·Margery A ConnellyDavid L Williams
Jan 17, 2004·The Journal of Biological Chemistry·Erik R M EckhardtDeneys R van der Westhuyzen
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Patricia G YanceyGeorge H Rothblat
Feb 27, 2001·Nature Immunology·D W WolanI A Wilson
Jul 31, 2014·The Journal of Biological Chemistry·Michael C Phillips
Apr 20, 2005·The Journal of Biological Chemistry·Debin Lan, David L Silver
May 2, 2009·Rejuvenation Research·Hicham Berrougui, Abdelouahed Khalil
Dec 7, 2018·The Journal of Membrane Biology·Alexander D DergunovDmitry Y Litvinov

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.